Anticoagulants in pregnancy

Current Obstetrics and Gynaecology

Volumn 6, Issue 2, 1996, Pages 111-118

  Horn, E H ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTEIN C; PROTEIN S; PROTHROMBIN; STEROID; VITAMIN K GROUP; WARFARIN;

ALLERGIC REACTION; ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; FEMALE; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABOR; LUNG EMBOLISM; MATERNAL MORTALITY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PREGNANCY; RECURRENT ABORTION; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOGENESIS; THROMBOCYTOPENIA; THROMBOEMBOLISM; URTICARIA;

EID: 0029736794     PISSN: 09575847     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-5847(96)80026-6     Document Type: Conference Paper

References (14)

1. Hirsh J. Heparin. N Engl J Med 1991; 324: 1565-1574
2. Danielsson A, Raub E, Lindahl U et al. Role of ternary complexes in which heparin binds both antithrombin and proteinase in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem 1986; 261: 15467-15473
3. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17
4. Colvin BT, Barrowcliffe TW (on behalf of the BCSH Haemostasis and Thrombosis Task Force). The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: Second Revision). J Clin Pathol 1993; 46: 97-103
5. Barrowcliffe TW. Low molecular weight heparin(s). British Journal of Haematology 1995; 90: 1-7
6. Warkentin TE, Levine MN, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low molecular weight or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335
7. Flessa HC, Kapstrom AB, Glueck HI, Will JJ. Placental transport of heparin. Am J Obstet Gynecol 1965; 93: 570-573
8. Andrew M, Boneu B, Cade J et al. Placental transport of low molecular weight heparin in the pregnant sheep. Br J Haematol 1985; 59: 103-108
9. Omri A, Delaloye JF, Anderson H, Bachman F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the secnd trimester of pregnancy. Thromb Haemost 1989; 61: 555-556
10. Levine MN, Raskob G, Landefeld S, Hirsh J. Haemorrhagic complications of anticoagulant treatment. Chest 1995; 108: 276S-290S
11. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of randomized trials in general, orthopaedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1173
12. Kakkar VV, Cohen AT, Edmonson RA et al. Low molecular weight versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1993; 341: 259-265
13. Hull RD, Raskob GE, Pineo GF et al. Subcutaneous low molecular weight heparin compared with continuous IV heparin in the treatment of proximal vein thrombosis. N Engl J Med 1992; 326: 7975-7982
14. Howell R, Fidler J, Letsky E, de Swiet M. The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial. Br J Obstet Gynaecol 1983; 90: 1124-1128